Increased fracture rates in Turner's syndrome: a nationwide questionnaire survey

被引:92
作者
Gravholt, CH [1 ]
Vestergaard, P
Hermann, AP
Mosekilde, L
Brixen, K
Christiansen, JS
机构
[1] Aarhus Univ Hosp, Aarhus Kommune Hosp, Dept Endocrinol & Diabet M, DK-8000 Aarhus C, Denmark
[2] Aarhus Univ Hosp, Aarhus Kommune Hosp, Med Res Labs, DK-8000 Aarhus C, Denmark
[3] Aarhus Univ Hosp, Aarhus Kommune Hosp, Dept Endocrinol & Metab C, DK-8000 Aarhus C, Denmark
[4] Odense Univ Hosp, Dept Endocrinol, DK-5000 Odense, Denmark
关键词
D O I
10.1046/j.1365-2265.2003.01807.x
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
BACKGROUND AND OBJECTIVES Reduced bone mineral content (BMC) and bone mineral density (BMD) have previously been reported in Turner's syndrome, although appropriate GH treatment and early induction of puberty seem to permit normal bone mass accumulation. Furthermore, an increased risk of fractures and osteoporosis have been reported in a registry study. The aim of the present study was to further characterize the risk of fractures in TS and to explore risk factors, in a historical follow-up survey based on a self-administered questionnaire. STUDY GROUPS The questionnaire was issued to all females with TS (n = 632) in Denmark and to 1888 randomly selected controls (C) matched for age and geographical region. A total of 322 patients (51%) and 1169 controls (62%) returned the questionnaire. RESULTS TS women were younger than C (30 years, range: 1-73 years vs. 34 years, range 2-82 years, P < 0.0005), smoked less often (17%vs. 27%, P < 0.0005), and had less frequent spontaneous menstruation (18%vs. 86%, P < 0.0005). In contrast, they used hormonal replacement therapy (HRT) more often (71%vs. 7%, P < 0.0005). The median age at start of HRT was 16 years (range 8-59 years) in TS vs. 42 years (range 12-53 years) in C (P < 0.0005). Above the age of 15 years, 83% of TS and 8% of C used HRT. GH had been used by 37% of TS but only 0.2% of C. Both type 1 and 2 diabetes were increased sevenfold among TS. Altogether, 77 individuals with TS had 109 fractures. The fracture risk was increased in TS [hazard ratio (HR, status) 1.35, confidence interval (CI) 1.04-1.75, P = 0.025]. Time to first fracture was reduced in TS (53 +/- 2 vs. 63 +/- 1; log-rank P = 0.03). Spontaneous menstruation was protective in females above 13 years of age (HR: 0.70, CI 0.54-0.93, P = 0.012). A history of parental fractures increased the risk (HR 1.92, CI 1.62-2.27, P < 0.001). Fractures of the forearm was more frequent among TS (P = 0.02). CONCLUSION The present nationwide survey, based on questionnaires, confirms an increased risk of early fractures in TS, especially in those without ovarian function and with a positive family history of fracture and osteoporosis. It thereby emphasizes the need for being vigilant with respect to BMD measurements in these patients.
引用
收藏
页码:89 / 96
页数:8
相关论文
共 34 条
[1]
BEALS RK, 1973, CLIN ORTHOP RELAT R, P19
[2]
Volumetric bone mineral density in young women with Turner's syndrome treated with estrogens or estrogens plus growth hormone [J].
Bertelloni, S ;
Cinquanta, L ;
Baroncelli, GI ;
Simi, P ;
Rossi, S ;
Saggese, G .
HORMONE RESEARCH, 2000, 53 (02) :72-76
[3]
Bone mineral density in children and adolescents: Relation to puberty, calcium intake, and physical activity [J].
Boot, AM ;
deRidder, MAJ ;
Pols, HAP ;
Krenning, EP ;
KeizerSchrama, SMPFD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (01) :57-62
[4]
OSTEOPOROSIS IN OVARIAN DYSGENESIS [J].
BROWN, DM ;
JOWSEY, J ;
BRADFORD, DS .
JOURNAL OF PEDIATRICS, 1974, 84 (06) :816-820
[5]
Spontaneous, but not induced, puberty permits adequate bone mass acquisition in adolescent Turner syndrome patients [J].
Carrascosa, A ;
Gussinye, M ;
Terradas, P ;
Yeste, D ;
Audí, L ;
Vicens-Calvet, E .
JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (10) :2005-2010
[6]
Osteoporosis in Turner's syndrome and other forms of primary amenorrhoea [J].
Davies, MC ;
Gulekli, B ;
Jacobs, HS .
CLINICAL ENDOCRINOLOGY, 1995, 43 (06) :741-746
[7]
Undiagnosed morbidity in adult women with Turner's syndrome [J].
Garden, AS ;
Diver, MJ ;
Fraser, WD .
CLINICAL ENDOCRINOLOGY, 1996, 45 (05) :589-593
[8]
Prenatal and postnatal prevalence of Turner's syndrome: A registry study [J].
Gravholt, CH ;
Juul, S ;
Naeraa, RW ;
Hansen, J .
BMJ-BRITISH MEDICAL JOURNAL, 1996, 312 (7022) :16-21
[9]
Morbidity in Turner Syndrome [J].
Gravholt, CH ;
Juul, S ;
Naeraa, RW ;
Hansen, J .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1998, 51 (02) :147-158
[10]
Marked disproportionality in bone size and mineral, and distinct abnormalities in bone markers and calcitropic hormones in adult Turner syndrome: A cross-sectional study [J].
Gravholt, CH ;
Lauridsen, AL ;
Brixen, K ;
Mosekilde, L ;
Heickendorff, L ;
Christiansen, JS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (06) :2798-2808